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In the early years of the HIV epidemic, 
researchers and health workers assumed 
that the partners of HIV-positive indi-
viduals would also be infected. But in 
1988, Susan Allen, then a researcher at 
UCSF, made a startling discovery. While 
tracking HIV in pregnant Rwandan 
women, Allen found that 14% of her 
1,500 research subjects did not share the 
same HIV status as their partners (1). 
To Allen, this discordance made these 
women and their partners an ideal co-
hort both to understand the factors 
that determine virus transmission and to 
identify strategies to prevent it.
Allen soon started a program in which 
both partners received counseling about 
prevention strategies and were routinely 
tested. Her approach 
had a huge payoff: HIV 
incidence among coun-
seled couples is 50–70% 
lower than among non-
counseled couples (2).
Allen’s progress came 
to a brutal stop during 
the Rwandan geno-
cide. Hundreds of her 
subjects and half of her 
program’s staff were 
killed. But rather than return to the 
United States, she used research funds 
formerly bound for Rwanda to start a 
similar program in Zambia.
Today, Allen’s program—known as 
the Rwanda Zambia HIV Research 
Group—includes the largest and longest-
standing cohort of HIV-discordant 
couples in the world. It has helped to 
identify strategies that reduce HIV trans-
mission and to uncover the effects of the 
host’s genotype and immune response 
on the evolution of the virus (3, 4).
JOURNEY TO AFRICA
You were poised to start a surgical career 
after fi  nishing medical school. How did 
you end up as a HIV researcher in 
Africa instead?
When AIDS started to hit the radar in 
1984, I was doing my residency in pathol-
ogy in San Francisco, which turned out 
to be one of the epicenters of the epi-
demic. One of the guest speakers at the 
hospital where I was doing autopsies on 
young, AIDS-ravaged gay men was a 
Belgian internist who had treated African 
AIDS patients. The internist described 
otherwise healthy people dying of dis-
eases that shouldn’t have been lethal—
something that we were also seeing among 
the AIDS victims in San Francisco. 
The patients were diff   erent, but the 
mortality was the same.
This doctor had access to blood 
samples from AIDS patients in Kigali, 
the capital of Rwanda. But these were 
the times before the virus had been 
isolated, before there were blood tests 
to detect it. So the doctor and his col-
leagues in Rwanda had a hard time fig-
uring out if this new disease was different 
from other endemic tropical diseases.
I approached the speaker and sug-
gested that they needed a pathology lab 
to diagnose the infections. He offered to 
write me a letter of introduction to the 
Rwandan Ministry of Health if I could 
find the funding to set up a diagnostic 
laboratory in Kigali. 18 months later, I 
landed in Kigali with seed money from 
UCSF and the state of California.
Had your medical training in the States 
prepared you to cope with the realities of 
doing science in Rwanda?
Because one doesn’t learn very much about 
tropical medicine during medical school in 
the US, I did a three-month intensive 
course in this subject at the Liverpool 
School of Tropical Medicine in the UK.
But it was really my childhood that 
made it easy for me to settle in. I grew 
up in Brazil and Lebanon. My parents 
had put me in French schools wherever 
we went because these schools had the 
same books and curriculum everywhere, 
unlike the American schools. So I spoke 
fluent French, which was a must to 
survive in Rwanda in those days.
Going solo like that, did you ever feel 
like you were stepping into the unknown?
The people at the hospital in Kigali made 
me feel very welcome, so I never felt 
alone or abandoned. And my mentors 
back at UCSF—people like Jay Levy and 
John Ziegler—were very supportive of 
my work, although they thought I was a 
little crazy for choosing to do this over-
seas project. But I never felt like I was 
embarking on some new and foreign 
adventure. Having grown up overseas, 
going to Africa was like going home.
There were some limitations how-
ever. Communication with the outside 
world was one. Political interference 
was a bigger problem.
DISRUPTIVE POLITICS
Why did the government interfere with 
your work?
HIV was a politically sensitive issue in 
the early days. The fi  rst antibody tests for 
HIV detection were faulty and generated 
what later turned out to be a lot of false 
positive results. But the press coverage of 
these bloated numbers set off   a panic, 
which can be very destabilizing to African 
governments that are already just hang-
ing on by a thread.
The Rwandan officials did not want 
any discussion of HIV because they 
thought it would kill foreign investment 
and scare off the tourists who came to see 
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mountain gorillas—an industry that con-
stituted a significant part of the economy. 
The government, which later became the 
regime responsible for the genocide, had 
a very active secret service that began to 
follow me around, tap my phone, and 
open my mail. I wasn’t allowed to 
publish my results from 1986 until 1991.
How did you cope with such an eff  ective 
gag order?
Growing up in places like Lebanon, I’d de-
veloped a sense of discretion very early on 
about some things, like government cor-
ruption. I thought that it was too bad that 
I wasn’t allowed to discuss my work but 
fi  gured that it was alright as long as I could 
keep working. I made concessions such as 
calling my program “Project San Francis-
co” because it wouldn’t do me any good 
to put up a sign that said “Project HIV.”
Scientists working elsewhere in Africa 
were also under the same kind of pres-
sure from other governments and were 
prevented from publishing. We finally 
got to the point where our funding was 
threatened because the NIH and other 
agencies demanded to see results.
Because the group of scientists work-
ing on HIV in Africa was very small at 
that time, we met in closed door sessions 
with no press around. That was the only 
way we could communicate with each 
other and with our funding agencies.
Given your troubles with the authorities, 
how hard was it to recruit people 
into the studies?
The recurrent theme in the 22 years that 
I’ve been doing this work is that the target 
population is never the problem. The 
obstacles are usually the bureaucracies, and 
to some extent, the healthcare workers, 
who are more concerned with stigma 
and social issues and end up projecting 
their pessimism onto their patients. We 
approached the community directly 
with our intentions, and they were over-
whelmingly eager to be tested.
When we set up Project San Francisco 
to counsel the women who were coming 
in to be tested, I sat in on the first 700 or 
so counseling sessions to get a feeling of 
what these women were able to grasp 
from what we were telling them about 
how to protect themselves from HIV or 
how to prevent its transmission. I was very 
surprised by how quickly they understood 
the bottom line. They told me, “Thanks 
for the information, but you really need to 
talk to our husbands, because they are the 
ones who make decisions in our marriage 
about sexual matters.”
Is that how your idea of studying 
discordant couples came about?
That’s right. We encouraged the men to 
come in, and a third of them showed up 
despite having no incentives; we didn’t 
even reimburse their transport costs. That’s 
when we discovered the phenomenon of 
discordant couples. We were making good 
progress in terms of recruiting and educat-
ing people until the genocide forced us to 
fl  ee. We relocated the program to Zambia, 
and soon after, I shifted base from UCSF 
to the University of Alabama system.
REBUILDING CAREER AND COHORT
Why did you move?
I had to leave UCSF because there was 
no tenure there, and San Francisco was 
an incredibly expensive place for a single 
mother with two young kids and a career 
that depended on the stability of war 
zones. So I moved to Alabama in 1996 
until fi  nancial troubles forced the closure 
of my department. And without students 
interested in international health, I 
could not recruit interns for our sites 
in Africa. So my husband, whom I met 
there, and I decided to move to a place 
where there were more people interest-
ed in global health. We came to Emory 
University in 2004.
What’s the current status of the 
discordant couples study project?
We went back to Rwanda after things 
calmed down and now have about 2,000 
couples spread over three sites there 
and in Zambia. We 
have money from a 
variety of sources, 
including the Interna-
tional AIDS Vaccine 
Initiative. We’ve done 
clinical trials both of 
behavioral interven-
tions like condom use 
and family planning as 
well as of antiviral drugs like acyclovir. 
The sites are also ready for vaccine trials.
Our biggest focuses at the moment 
are the prevention of transmission and 
the study of the natural history of the 
disease. The cohort is a great source of 
samples to study the characteristics of 
the transmitted virus and the virus that 
establishes infection in a new host, 
because this information is likely to help 
in the design of effective vaccines.
Are you closer to understanding why 
discordancy exists, that is, why some 
people are resistant?
We’re working with virologists and 
geneticists to answer that question. Basi-
cally, everyone is vulnerable, and everyone 
who gets infected is contagious to some 
degree. Our collaborators have identifi  ed 
HLA types that are associated with being 
contagious or being vulnerable. So we are 
uncovering risk factors for HIV infection 
and ways to prevent the spread of HIV, 
but there is a lot more left to learn.
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HIV-discordant couples are counseled at an HIV testing center.
“We are 
uncovering risk 
factors for HIV 
infection and 
ways to prevent 
the spread.”